Evidence map›Paper›PMID 29943058›Full record

Trial reportSurgical endoscopy2019

Long-term follow-up after sleeve gastrectomy versus Roux-en-Y gastric bypass versus one-anastomosis gastric bypass: a prospective randomized comparative study of weight loss and remission of comorbidities.

Jaime Ruiz-Tovar, Miguel Angel Carbajo, Jose Maria Jimenez, Maria Jose Castro, Gilberto Gonzalez, Javier Ortiz-de-Solorzano, Lorea Zubiaga

Retracted 2 registry-linked trialsAbstract readComparative StudyRandomized Controlled TrialRetracted Publication
PubMed Publisher
In one paragraph

Trial report in Surgical endoscopy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. It is linked to 2 registered trials, which are not on this map. Cited by 63 papers, 17 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 17 pooled it
19.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03467646 phase3completednot on this map

Long-term Follow up After Sleeve Gastrectomy Versus Roux-en-Y Gastric Bypass Versus One-Anastomosis Gastric Bypass: A Comparative Study of Weight Loss

TypeinterventionalSponsorHospital General Universitario ElcheRan2010 to 2017Enrolled600ConditionsWeight LossArmsSleeve Gastrectomy, Roux-en-Y gastric bypass, One-Anastomosis Gastric Bypass
NCT06077955 naunknown statusnot on this mapstarted 2023, after this paper: background citation

The Incidence of Gastrojejunostomy Ulceration After MGB-OAGB: Comparison of Hand-Sewn and Stapled Techniques of Anastomosis Formation. Multicenter Prospective Randomized Clinical Trial Study

TypeinterventionalSponsorFederal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of HealthRan2023 to 2025Enrolled300ConditionsUlcer PepticArmsMini-gastric bypass with stapled anastomosis, Mini-gastric bypass with hand-sewn anastomosis
3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 17 syntheses or guidelines pooled it, 128 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. One Anastomosis Gastric Bypass Versus Sleeve Gastrectomy for Obesity: a Systemic Review and Meta-analysis.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2023
    Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Guideline
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Pooled it
  16. Pooled it
  17. Pooled it
  18. SHORTEN PREOPERATIVE FASTING AND INTRODUCING EARLY EATING ASSISTANCE IN RECOVERY AFTER GASTROJEJUNAL BYPASS?Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery · 2022
    Trial
  19. Trial
  20. Trial

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Jaime Ruiz-TovarBariatric Surgery Unit, Centro de Excelencia para el Estudio y Tratamiento de la Obesidad, Valladolid, Spain. jruiztovar@gmail.com.ORCID http://orcid.org/0000-0002-8505-2605
Miguel Angel CarbajoBariatric Surgery Unit, Centro de Excelencia para el Estudio y Tratamiento de la Obesidad, Valladolid, Spain.
Jose Maria JimenezBariatric Surgery Unit, Centro de Excelencia para el Estudio y Tratamiento de la Obesidad, Valladolid, Spain.
Maria Jose CastroBariatric Surgery Unit, Centro de Excelencia para el Estudio y Tratamiento de la Obesidad, Valladolid, Spain.
Gilberto GonzalezBariatric Surgery Unit, Centro de Excelencia para el Estudio y Tratamiento de la Obesidad, Valladolid, Spain.
Javier Ortiz-de-SolorzanoBariatric Surgery Unit, Centro de Excelencia para el Estudio y Tratamiento de la Obesidad, Valladolid, Spain.
Lorea ZubiagaBariatric Surgery Unit, Centro de Excelencia para el Estudio y Tratamiento de la Obesidad, Valladolid, Spain.
Hospital General Universitario de Elche · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOne-Anastomosis Gastric Bypass (OAGB) has exponentially increased in the last decade, as it is associated with very low complications, mortality, readmissions and reoperations rates, and shows excellent short- and long-term benefits of weight loss and resolution of comorbidities. The aim of this study was to compare the effect of SG, RYGB, and OAGB, on short- and long-term weight loss and comorbidities resolution.

methodsA prospective randomized clinical study of all morbidly obese patients undergoing SG, RYGB, and OAGB, as primary bariatric procedures, was performed. Patients were randomly assigned into 3 groups: those patients undergoing SG, those ones undergoing RYGB and those ones undergoing OAGB. BMI, excess BMI loss (EBMIL) and remission of type 2 diabetes (T2DM), hypertension (HT), and dyslipidemia (DL) were assessed.

results600 patients were included in the study, 200 in each group. Follow-up rate at 5 years postoperatively was 91% in SG group, 92% in RYGB, and 90% in OAGB. OAGB achieves significantly greater EBMIL than RYGB and SG at 1, 2, and 5 years (p < 0.001, respectively). At 5 years, OAGB achieves significantly greater remission of T2DM (p = 0.027), HT (p = 0.006), and DL (p < 0.001) than RYGB and SG. RYGB did not show significant superiority than SG in short- and long-term remission of T2DM and HT, but achieves greater remission of DL (p < 0.001).

conclusionOAGB achieves superior mid- and long-term weight loss than RYGB and SG. There are no significant differences in weight loss between SG and RYGB at 1, 2, and 5 years. OAGB achieves better short- and long-term resolution rates of DM, HT, and DL than SG and RYGB. RYGB and SG obtain similar T2DM and HT remissions, but RYGB reaches significantly greater rates of DL remission. ClinicalTrials.gov Identifier: NCT03467646.

Indexed as

Weight LossAdultBody Mass IndexDiabetes Mellitus, Type 2DyslipidemiasFemaleFollow-Up StudiesGastrectomyGastric BypassHumansHypertensionMaleMiddle AgedObesity, MorbidProspective StudiesReoperationDyslipidemiaHypertensionOne-anastomosis gastric bypassRoux-en-Y gastric bypassSleeve gastrectomyType 2 diabetes mellitus

Identifiers

PMID29943058
OpenAlexW2810885197

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.